Bardin Hill Management Partners’s Array Biopharma Inc ARRY Stock Holding History

Bardin Hill Management Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-605,879	Closed	-$28.1M	–	38
2019 Q2	$28.1M	Buy	+605,879	New	+$17M	3.88%	11

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Bardin Hill Management Partners's ARRY Position: Q3 2019 in Review

Bardin Hill Management Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 605,879 shares — an estimated $28.1M sold.

Bardin Hill Management Partners first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $28.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Bardin Hill Management Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Bardin Hill Management Partners sold 605,879 Array Biopharma Inc shares in Q3 2019, an estimated $28.1M.
Bardin Hill Management Partners first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Bardin Hill Management Partners's Array Biopharma Inc position peaked at $28.1M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Bardin Hill Management Partners's 13F filing for Q3 2019, filed 14 Nov 2019.